Astalake Bio is advancing an integrated biotechnology portfolio that combines bioinformatics, computational biology, and genetic engineering to address challenges in biological production, plant health, animal health, and environmental resilience.

The company’s bioinformatics-driven biomanufacturing approach focuses on the development of scalable production technologies for high-value plant-derived bioactive compounds. By integrating computational methods with proprietary genetic engineering technologies, Astalake Bio aims to accelerate the discovery, optimization, and production of phytochemicals and specialty metabolites.

Three complementary biotechnology platforms

Astalake Bio’s technology portfolio includes three complementary platforms:

• ASTALAKE™ — High-Value Metabolite Biotechnology: Developing biotechnology approaches for the production of plant-derived bioactive compounds and specialty metabolites, with potential applications in plant and animal health.
• AFINGEN® — Plant Biotechnology: Developing precision plant biotechnology approaches to investigate and improve agriculturally relevant crop traits.
• CLIMATE BIO® — Agricultural Climate Biotechnology: Exploring biotechnology applications that support agricultural resilience and adaptation to changing environmental conditions.

Together, these platforms reflect Astalake Bio’s strategy of integrating biological engineering, computational capabilities, and application-focused biotechnology development.

Through this portfolio, Astalake Bio aims to advance nature-inspired biotechnology solutions for agriculture, biological production, and environmental resilience.

Learn more: https://astalakebio.com/